Alpa Laboratories Ltd.
| BSE: 532878 | Sector: Health care |
| NSE: ALPA | ISIN Code: INE385I01010 |
| BSE 00:00 | 02 Feb | 65.35 |
-1.50 (-2.24%) |
OPEN
68.00 |
HIGH
68.65 |
LOW
64.25 |
| NSE 00:00 | 02 Feb | 64.50 |
-2.90 (-4.30%) |
OPEN
68.00 |
HIGH
68.30 |
LOW
64.05 |
| OPEN | 68.00 |
| PREVIOUS CLOSE | 66.85 |
| VOLUME | 28859 |
| 52-Week high | 91.95 |
| 52-Week low | 48.90 |
| P/E | 29.84 |
| Mkt Cap.(Rs cr) | 138 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alpa Laboratories Ltd. (ALPA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 1024.95 | -7.35 | -0.71 | 2957.93 |
| Divi's Lab. | 3267.15 | -88.70 | -2.64 | 2948.54 |
| Glenmark Pharma. | 389.25 | 6.60 | 1.72 | 1997.79 |
| Glaxosmi. Pharma | 1235.45 | -15.30 | -1.22 | 1690.53 |
| Dr Reddy's Labs | 4370.05 | 19.55 | 0.45 | 1623.20 |
| Alkem Lab | 3074.60 | 41.50 | 1.37 | 1541.25 |
| Aurobindo Pharma | 409.90 | -2.65 | -0.64 | 1454.71 |
| Gland Pharma | 1275.95 | 12.90 | 1.02 | 1212.16 |
| Torrent Pharma. | 1540.70 | 7.00 | 0.46 | 991.45 |
| Sanofi India | 5416.85 | -25.70 | -0.47 | 944.40 |
| Ipca Labs. | 856.50 | 2.95 | 0.35 | 870.94 |
| Zydus Lifesci. | 432.60 | -3.00 | -0.69 | 857.90 |
| Abbott India | 20484.15 | -214.25 | -1.04 | 798.70 |
| Laurus Labs | 338.80 | 4.25 | 1.27 | 750.09 |
| Ajanta Pharma | 1189.55 | 5.45 | 0.46 | 719.86 |
| Apollo Hospitals | 4233.00 | -35.10 | -0.82 | 665.20 |
| Pfizer | 3853.05 | 42.10 | 1.10 | 612.56 |
| Suven Pharma | 488.20 | -3.60 | -0.73 | 558.10 |
| Alembic Pharma | 540.20 | 0.20 | 0.04 | 543.55 |
| Glenmark Life | 380.40 | 0.50 | 0.13 | 418.72 |
Quick Links for Alpa Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
